SCALMIBIO
ScalmiBio minimizes side-effects of oncology and immuno-oncology antibody therapeutics.
SCALMIBIO
Social Links:
Industry:
Biotechnology Life Science
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.scalmibio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Content Delivery Network Apache Google Apps For Business Google Maps JsDelivr BootstrapCDN
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Founder
More informations about "ScalmiBio"
ScalmiBio - Crunchbase Company Profile & Funding
ScalmiBio is located in San Carlos, California, United States. Who are ScalmiBio 's competitors? Alternatives and possible competitors to ScalmiBio may include Werewolf Therapeutics , Leap …See details»
ScalmiBio Company Profile 2024: Valuation, Investors ... - PitchBook
Who is the founder of ScalmiBio? Marija Vrljic and Jaume Pons Ph.D are the founders of ScalmiBio. Where is ScalmiBio headquartered? ScalmiBio is headquartered in San Carlos, …See details»
ScalmiBio - Products, Competitors, Financials, Employees, …
ScalmiBio minimizes side-effects of oncology and immuno-oncology antibody therapeutics. On October 7th, 2021, ScalmiBio was acquired by ALX Oncology at a valuation between $4.5M …See details»
ScalmiBio, Inc. Company Profile | San Francisco, CA | Competitors ...
Find company research, competitor information, contact details & financial data for ScalmiBio, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
ScalmiBio - Contacts, Employees, Board Members, Advisors
Organization. ScalmiBio . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. ScalmiBio has 2 current …See details»
ScalmiBio - Company Profile - Tracxn
Nov 27, 2024 ScalmiBio - Developer of an antibody to minimise the side effect of cancer drugs. Raised funding from 1 investor. Founded by Jaume Pons and Marija Vrljic in the year 2016. …See details»
ALX Oncology acquires ScalmiBio - 2021-10-07 - Crunchbase
Oct 7, 2021 ScalmiBio ScalmiBio minimizes side-effects of oncology and immuno-oncology antibody therapeutics. Acquiring Organization: ALX Oncology ALX Oncology is a preclinical …See details»
SCALMIBIO, INC - VentureRadar
Similar Companies: Xilio Therapeutics USA Publicly Traded Akriveia Therapeutics is discovering and developing the next generation of cancer immunotherapies. Akriveia's new agents offer …See details»
Alliance of Chief Executives - ALX Oncology Acquires ScalmiBio
Alliance of Chief Executives, LLC 2175 N. California Blvd., Suite 605 Walnut Creek, CA 94596. 925-942-2400 Office; 925-956-4424 Fax; Email: [email protected] Get In TouchSee details»
Scalmibio: An oncology biotech startup from idea to exit
Marija Vrljic, Ph.D., is the co-founder and CEO of Scalmibio, an early-stage biotechnology startup that developed a transformational technology focused on on...See details»
Scalmibio: An oncology biotech (antibody prodrugs) startup from …
Dec 14, 2021 Summary: Marija Vrljic, Ph.D., is the co-founder and CEO of Scalmibio, an early-stage biotechnology startup that developed a transformational technology focused on …See details»
ALX Oncology (ALXO) Acquires ScalmiBio - StreetInsider.com
Oct 7, 2021 ScalmiBio’s SHIELD technology is designed to minimize interaction of an antibody therapeutic with normal tissue and maximize its target binding capability within tumor …See details»
ScalmiBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jul 15, 2024 ScalmiBio minimizes side-effects of oncology and immuno-oncology antibody therapeutics.See details»
Wilson Sonsini Advises ALX Oncology on Acquisition of ScalmiBio
On October 7, 2021, ALX Oncology Holdings Inc. (ALX Oncology), a clinical-stage immuno-oncology company, and ScalmiBio, Inc., announced that ALX has acquired ScalmiBio. Wilson …See details»
ALX Oncology acquires ScalmiBio to expand pipeline - Seeking …
Oct 7, 2021 The clinical-stage immuno-oncology company has made an initial cash payment of ~$4.5M to ScalmiBio stockholders. An additional cash payment of $2M will be made at the one …See details»
ALX Oncology Strengthens Immuno-Oncology Pipeline with
Oct 7, 2021 ALX Oncology further expands its pipeline with plans to develop new anti-cancer drug candidates based on ScalmiBio’ s platform; these new molecules will be designed to …See details»
ALX Oncology Strengthens Immuno-Oncology Pipeline with …
Oct 7, 2021 ALX Oncology further expands its pipeline with plans to develop new anti-cancer drug candidates based on ScalmiBio’s platform; these new molecules will be designed to …See details»
ScalmiBio - Crunchbase
ScalmiBio minimizes side-effects of oncology and immuno-oncology antibody therapeutics.See details»
ALX Oncology Strengthens Immuno-Oncology Pipeline with
Oct 7, 2021 ALX Oncology further expands its pipeline with plans to develop new anti-cancer drug candidates based on ScalmiBio’s platform; these new molecules will be designed to …See details»
Ucraina Russia, le ultime notizie di oggi 6 dicembre sulla guerra di ...
2 days ago I due leader hanno avuto, inoltre, uno scambio sulle prossime iniziative diplomatiche, anche in vista del Consiglio Europeo. Infine, il presidente del Consiglio ha ricordato l'impegno …See details»